Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
BMC Cancer. 2024 Jan 24;24(1):126. doi: 10.1186/s12885-023-11716-2.
Adolescents and young adults (AYAs) with cancer, defined as individuals aged 15-39 years at initial cancer diagnosis, form a unique population; they face age-specific issues as they transition to adulthood. This paper presents the protocol for the development of a core outcome set (COS) for AYAs with cancer.
The methodological standards from the Core Outcome Measures in Effectiveness Trials (COMET) and the International Consortium for Health Outcomes Measurement (ICHOM) for COS development will guide the development of the COS for AYAs with cancer. The project will consist of the following phases: (1) define the scope of the COS; (2) establish the need for a COS in this field (3) assemble an international, multi-stakeholder working group; (4) develop a detailed protocol; (5) determine "what to measure" (i.e., outcomes); (6) determine "how to measure" (i.e., measures); and (7) determine "case-mix" variables.
The development of a COS for AYAs with cancer will facilitate the implementation of efficient and relevant standards for data collection, both for clinical trials and in routine healthcare, thereby increasing the usefulness of these data to improve the value of the care given to these underserved young cancer patients.
青少年和年轻成人(AYAs)患有癌症,定义为初始癌症诊断时年龄为 15-39 岁的个体,他们形成了一个独特的人群;随着他们向成年期过渡,他们面临着特定于年龄的问题。本文介绍了为癌症 AYAs 制定核心结局集(COS)的方案。
来自核心结局测量在有效性试验(COMET)和国际健康结局测量联合会(ICHOM)的方法标准将指导癌症 AYAs 的 COS 制定。该项目将包括以下阶段:(1)定义 COS 的范围;(2)确定在该领域需要 COS;(3)组建一个国际、多利益相关者工作组;(4)制定详细方案;(5)确定“要测量什么”(即结局);(6)确定“如何测量”(即测量方法);以及(7)确定“病例组合”变量。
为癌症 AYAs 制定 COS 将有助于实施高效和相关的数据收集标准,既适用于临床试验,也适用于常规医疗保健,从而提高这些数据的有用性,以改善对这些服务不足的年轻癌症患者的护理价值。